BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11998214)

  • 1. [Endometrial hyperplasias resistant to progestins: alternatives to traditional treatments].
    Brun JL; Belaisch J; Rivel J; Hocké C
    Gynecol Obstet Fertil; 2002 Mar; 30(3):244-51. PubMed ID: 11998214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Endometrial hyperplasia: A review].
    Brun JL; Descat E; Boubli B; Dallay D
    J Gynecol Obstet Biol Reprod (Paris); 2006 Oct; 35(6):542-50. PubMed ID: 17003742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of non-atypic endometrial hyperplasia using thermal balloon endometrial ablation therapy.
    Järvelä IY; Santala M
    Gynecol Obstet Invest; 2005; 59(4):202-6. PubMed ID: 15731561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chinese guidelines on the management of endometrial hyperplasia.
    Li L; Zhu L;
    Eur J Surg Oncol; 2024 Jul; 50(7):108391. PubMed ID: 38735237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histologic alterations in endometrial hyperplasia and well-differentiated carcinoma treated with progestins.
    Wheeler DT; Bristow RE; Kurman RJ
    Am J Surg Pathol; 2007 Jul; 31(7):988-98. PubMed ID: 17592264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of hyperplasias of the endometrium].
    Favreau JJ
    Rev Fr Gynecol Obstet; 1987 May; 82(5):351-4. PubMed ID: 3602811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Methods and efficacy of medical and surgical treatment of non functional menorrhagia].
    Brun JL; André G; Descat E; Creux H; Vigier J; Dallay D
    J Gynecol Obstet Biol Reprod (Paris); 2008 Dec; 37 Suppl 8():S368-83. PubMed ID: 19268216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic Progestins and Progestin-Releasing Intrauterine Device Therapy for Premenopausal Patients With Endometrial Intraepithelial Neoplasia.
    Suzuki Y; Chen L; Hou JY; St Clair CM; Khoury-Collado F; de Meritens AB; Matsuo K; Melamed A; Hershman DL; Wright JD
    Obstet Gynecol; 2023 May; 141(5):979-987. PubMed ID: 37023446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of the levonorgestrel releasing intrauterine system on endometrial hyperplasia: an Australian study and systematic review.
    Buttini MJ; Jordan SJ; Webb PM
    Aust N Z J Obstet Gynaecol; 2009 Jun; 49(3):316-22. PubMed ID: 19566568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levonorgestrel intra-uterine system as a treatment option for complex endometrial hyperplasia.
    Haoula ZJ; Walker KF; Powell MC
    Eur J Obstet Gynecol Reprod Biol; 2011 Nov; 159(1):176-9. PubMed ID: 21741152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effectiveness of a levonorgestrel-releasing intrauterine system (LNG-IUS) in the treatment of endometrial hyperplasia--a long-term follow-up study.
    Varma R; Soneja H; Bhatia K; Ganesan R; Rollason T; Clark TJ; Gupta JK
    Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):169-75. PubMed ID: 18440693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endometrial hyperplasia with secretory changes.
    Tresserra F; Lopez-Yarto M; Grases PJ; Ubeda A; Pascual MA; Labastida R
    Gynecol Oncol; 2003 Mar; 88(3):386-93. PubMed ID: 12648591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fertility-Sparing Treatment of Early Endometrial Cancer and Complex Atypical Hyperplasia in Young Women of Childbearing Potential.
    Pronin SM; Novikova OV; Andreeva JY; Novikova EG
    Int J Gynecol Cancer; 2015 Jul; 25(6):1010-4. PubMed ID: 25950126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levonorgestrel-releasing intrauterine system vs oral progestins for non-atypical endometrial hyperplasia: a systematic review and metaanalysis of randomized trials.
    Abu Hashim H; Ghayaty E; El Rakhawy M
    Am J Obstet Gynecol; 2015 Oct; 213(4):469-78. PubMed ID: 25797236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleeding.
    Lethaby A; Farquhar C; Sarkis A; Roberts H; Jepson R; Barlow D
    Cochrane Database Syst Rev; 2000; (2):CD000402. PubMed ID: 10796715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relapse of endometrial hyperplasia after conservative treatment: a cohort study with long-term follow-up.
    Gallos ID; Krishan P; Shehmar M; Ganesan R; Gupta JK
    Hum Reprod; 2013 May; 28(5):1231-6. PubMed ID: 23466671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical endometrial hyperplasia in an 18-year-old woman.
    Agorastos T; Vaitsi V; Vakiani A; Dinas K; Bontis J
    Arch Gynecol Obstet; 2003 Feb; 267(4):252-5. PubMed ID: 12592432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resectoscopic surgery may be an alternative to hysterectomy in high-risk women with atypical endometrial hyperplasia.
    Edris F; Vilos GA; Al-Mubarak A; Ettler HC; Hollett-Caines J; Abu-Rafea B
    J Minim Invasive Gynecol; 2007; 14(1):68-73. PubMed ID: 17218233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LNG-IUS versus oral progestogen treatment for endometrial hyperplasia: a long-term comparative cohort study.
    Gallos ID; Krishan P; Shehmar M; Ganesan R; Gupta JK
    Hum Reprod; 2013 Nov; 28(11):2966-71. PubMed ID: 23975691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term clinical outcomes following resectoscopic endometrial ablation of non-atypical endometrial hyperplasia in women with abnormal uterine bleeding.
    Vilos GA; Oraif A; Vilos AG; Ettler H; Edris F; Abu-Rafea B
    J Minim Invasive Gynecol; 2015 Jan; 22(1):66-77. PubMed ID: 25048567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.